Future advances in melanoma research

Thomas J Hornyak1

  • 1Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10/12N242, Bethesda, MD 20892, USA. hornyakt@mail.nih.gov

Clinics in Plastic Surgery
|November 17, 2009
PubMed

Insights

Melanoma research is advancing, identifying new therapeutic targets and adopting successful strategies from other cancers. Efforts are underway to overcome research roadblocks and increase support for this critical area.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma remains a significant health challenge.
  • Progress in understanding melanoma development has been slower compared to other cancers.

Purpose of the Study:

  • To highlight the promising future of melanoma research.
  • To identify key areas for advancing melanoma studies and therapies.

Main Methods:

  • Identifying specific mechanisms of oncogenic transformation in melanoma.
  • Leveraging successful research approaches from rapidly advancing malignancies.
  • Addressing systematic roadblocks hindering melanoma research.

Main Results:

  • New therapeutic targets for melanoma are being identified.
  • Interdisciplinary approaches are accelerating research progress.
  • Systematic barriers to melanoma research are being formally addressed.

Conclusions:

  • The future of melanoma research is promising due to identified mechanisms and adopted strategies.
  • Increased awareness and dedicated efforts are crucial for overcoming melanoma research challenges.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...